IDEXX Laboratories IDXX · USD
Health Care · Health Care Equipment & Supplies · US listing · 🇺🇸 United States
S&P 500Nasdaq-100
706.65
+4.53%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About IDEXX Laboratories
From its filings with the US Securities and Exchange Commission
IDEXX Laboratories is based in Westbrook, Maine and is incorporated in Delaware. Its shares trade on Nasdaq under the ticker IDXX. It is a member of the S&P 500 and Nasdaq-100. The SEC classifies its business as in vitro & in vivo diagnostic substances. In the fiscal year to 31 December 2025, it reported revenue of $4.30bn and net income of $1.06bn. At that date it held total assets of $3.35bn and shareholders' equity of $1.61bn. By business, Product revenue brought in 59.0% of revenue, followed by Service revenue at 41.0%.
Our Purpose is to be a great company that creates exceptional long-term value for our customers, employees, and stockholders by enhancing the health and well-being of pets, people, and livestock.
We operate primarily through three reportable business segments: Companion Animal Group, Water quality products, and Livestock, Poultry and Dairy. Our Other operating segment combines and presents our human medical diagnostic products business with our out-licensing arrangement because they do not meet the quantitative or qualitative thresholds for reportable segments.
Companion Animal Group (“CAG”) - Diagnostic and information management products and services for the companion animal veterinary industry, including point-of-care diagnostic solutions, outside reference laboratory services, and veterinary software and services.
We provide diagnostic capabilities that meet veterinarians’ diverse needs through a variety of modalities, including point-of-care diagnostic solutions and outside reference laboratory services. Regardless of modality utilized, veterinarians are provided with clinically relevant data which is integrated within our information management technologies. The result is a comprehensive view of patient diagnostic information that is easily accessible by both the veterinarian and pet owner.
Quoted from its 10-K, filed 20 Feb 2026. Read the filing on SEC.gov ↗
Company facts
- Sector
- Health Care
- Industry
- Health Care Equipment & Supplies
- Listed since
- 21 Jun 1991
- Employees
- 11,000
- Website
- idexx.com ↗
- Head office
- ONE IDEXX DRIVE, WESTBROOK, ME, 04092-2041
- Incorporated in
- DE
- Classification
- In Vitro & In Vivo Diagnostic Substances
- Filer status
- Large accelerated filer
Leadership
Pay as last reported
- Mr. Lawrence KingsleyIndependent Chairman of the Board$499,937
- Mr. Jonathan MazelskyPresident, Chief Executive Officer, Director, since 2012$13.0m
- Mr. Andrew EmersonExecutive Vice President, Chief Executive Officer, Treasurer
- Mr. Michael JohnsonChief Human Resources Officer, Executive Vice President
- Ms. Sharon UnderbergExecutive Vice President, General Counsel, Corporate Secretary$1.9m
- Mr. Michael EricksonExecutive Vice President and General Manager, Point of Care Diagnostics and Telemedicine
- Mr. Michael LaneExecutive Vice President and General Manager, Global Reference Laboratories, Diagnostic Solutions and Information Technology$3.7m
- Mr. Michael SchreckExecutive Vice President and General Manager, Veterinary Software and Services, Corporate Accounts and Customer Experience
- Mr. George FennellExecutive Vice President - Global CAG Commercial
- Dr. Tina HuntExecutive Vice President - Global Strategy and Commercial$3.7m
- Mr. Martin SmithExecutive Vice President - Global Operations and R&D$3.7m
- Ms. Irene BrittIndependent Director$363,653
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 86
- Environment
- 99
- Social
- 99
- Governance
- 60
- Direct emissions (scope 1)
- 16,458 t
- Energy emissions (scope 2)
- 18,557 t
- Women in the workforce
- 58%
- Carbon reduction policy
- Yes
- Human rights policy
- Yes
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.